119 related articles for article (PubMed ID: 12210074)
1. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
Becker KF; Kremmer E; Eulitz M; Schulz S; Mages J; Handschuh G; Wheelock MJ; Cleton-Jansen AM; Höfler H; Becker I
J Pathol; 2002 Aug; 197(5):567-74. PubMed ID: 12210074
[TBL] [Abstract][Full Text] [Related]
2. [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors].
Becker I; Becker KF; Kremmer E; Eulitz M; Handschuh G; Höfler H
Verh Dtsch Ges Pathol; 1999; 83():233-9. PubMed ID: 10714216
[TBL] [Abstract][Full Text] [Related]
3. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody.
Becker KF; Kremmer E; Eulitz M; Becker I; Handschuh G; Schuhmacher C; Müller W; Gabbert HE; Ochiai A; Hirohashi S; Höfler H
Am J Pathol; 1999 Dec; 155(6):1803-9. PubMed ID: 10595908
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
[TBL] [Abstract][Full Text] [Related]
5. Mutations of the human E-cadherin (CDH1) gene.
Berx G; Becker KF; Höfler H; van Roy F
Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
[TBL] [Abstract][Full Text] [Related]
6. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
[TBL] [Abstract][Full Text] [Related]
7. Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer.
Senekowitsch-Schmidtke R; Schuhmacher C; Becker KF; Nikula TK; Seidl C; Becker I; Miederer M; Apostolidis C; Adam C; Huber R; Kremmer E; Fischer K; Schwaiger M
Cancer Res; 2001 Apr; 61(7):2804-8. PubMed ID: 11306447
[TBL] [Abstract][Full Text] [Related]
8. Functional loss of E-cadherin and cadherin-11 alleles on chromosome 16q22 in colonic cancer.
Braungart E; Schumacher C; Hartmann E; Nekarda H; Becker KF; Höfler H; Atkinson MJ
J Pathol; 1999 Apr; 187(5):530-4. PubMed ID: 10398117
[TBL] [Abstract][Full Text] [Related]
9. Single amino acid substitutions in conserved extracellular domains of E-cadherin differ in their functional consequences.
Handschuh G; Luber B; Hutzler P; Höfler H; Becker KF
J Mol Biol; 2001 Nov; 314(3):445-54. PubMed ID: 11846558
[TBL] [Abstract][Full Text] [Related]
10. [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy].
Höfler H
Verh Dtsch Ges Pathol; 1999; 83():148-54. PubMed ID: 10714205
[TBL] [Abstract][Full Text] [Related]
11. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.
Becker KF; Reich U; Schott C; Becker I; Berx G; van Roy F; Höfler H
Hum Mutat; 1999; 13(2):171. PubMed ID: 10094558
[TBL] [Abstract][Full Text] [Related]
12. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
13. Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer.
Huiping C; Sigurgeirsdottir JR; Jonasson JG; Eiriksdottir G; Johannsdottir JT; Egilsson V; Ingvarsson S
Br J Cancer; 1999 Dec; 81(7):1103-10. PubMed ID: 10584868
[TBL] [Abstract][Full Text] [Related]
14. Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
Fuchs M; Hermannstädter C; Specht K; Knyazev P; Ullrich A; Rosivatz E; Busch R; Hutzler P; Höfler H; Luber B
J Cell Physiol; 2005 Mar; 202(3):805-13. PubMed ID: 15389640
[TBL] [Abstract][Full Text] [Related]
15. E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival.
Gamboa-Dominguez A; Dominguez-Fonseca C; Chavarri-Guerra Y; Vargas R; Reyes-Gutierrez E; Green D; Quintanilla-Martinez L; Luber B; Busch R; Becker KF; Becker I; Höfler H; Fend F
Hum Pathol; 2005 Jan; 36(1):29-35. PubMed ID: 15712179
[TBL] [Abstract][Full Text] [Related]
16. An alternatively spliced cadherin-11 enhances human breast cancer cell invasion.
Feltes CM; Kudo A; Blaschuk O; Byers SW
Cancer Res; 2002 Nov; 62(22):6688-97. PubMed ID: 12438268
[TBL] [Abstract][Full Text] [Related]
17. Combined evaluation of mucin antigen and E-cadherin expression may help select patients with gastric cancer suitable for minimally invasive therapy.
Tanaka M; Kitajima Y; Sato S; Miyazaki K
Br J Surg; 2003 Jan; 90(1):95-101. PubMed ID: 12520583
[TBL] [Abstract][Full Text] [Related]
18. Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.
Zhong XY; Zhang LH; Jia SQ; Shi T; Niu ZJ; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Ji JF
Histopathology; 2008 Apr; 52(5):560-8. PubMed ID: 18312357
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
20. Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays.
Oztas E; Avci ME; Ozcan A; Sayan AE; Tulchinsky E; Yagci T
Exp Mol Pathol; 2010 Oct; 89(2):182-9. PubMed ID: 20515682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
